Depo-Provera may be linked to uterine cancer, preliminary data imply.
D000818:Animals; D003692:Delayed-Action Preparations / Q000009:adverse effects; D005260:Female; D000882:Haplorhini; D008253:Macaca mulatta; D008525:Medroxyprogesterone / Q000009:adverse effects / Q000031:analogs & derivatives*; D014594:Uterine Neoplasms / Q000139:chemically induced*
D003692:Delayed-Action Preparations; D008525:Medroxyprogesterone